Generation of a monoclonal antibody directed against a human cell substrate adhesion molecule and the expression of the antigen in human tissues

Hybridoma

Volumn 16, Issue 1, 1997, Pages 77-83

  Coene, Elisabeth ^a   Schelfhout, Anne Marie ^a   De Ridder, Leo ^b   De Potter, Christian R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; EPITOPE; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN BINDING; ANTIGEN EXPRESSION; CELL ADHESION; CELL LINE; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; SKIN CARCINOMA; TISSUE DISTRIBUTION;

EID: 0030992479     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1997.16.77     Document Type: Conference Paper

References (21)

1. Fleming S: Cellular functions of adhesion molecules. J Pathol 1990;161:189-190.
2. Albelda SM: Biology of disease: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4-17.
3. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, and Buck CA: Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression. Cancer Res 1990;50:6757-6764.
4. Chan BMC, Matsuura N, Takada Y, Zetter BR, and Hemler ME: In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 1991;251:1600-1602.
5. McGregor BC, McGregor JL, Weiss LM, Wood GS, Hu CH, Boukerche H, and Warnke RA: Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am J Clin Pathol 1989;92:495-499.
6. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-185.
7. Navarro P, Gomez M, Pizarro A, Gamallo C, Quintanilla M, and Cano A: A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol 1991;115:517-533.
8. De Potter CR, Schelfhout AM, De Smet FH, Van Damme S, De Ridder L, Dhont E, and van Emmelo J: A monoclonal antibody directed against a human cell membrane antigen prevents cell substrate adhesion and tumor invasion. Am J Pathol 1994;144:95-103.
9. Steinbuch M, and Audran R: The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 1969;134:279-284.
10. Asplund T, and Heldin P: Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res 1994;54:4516-4523.
11. Jalkanen ST, Bargatze RF, Herron LR, and Bucher EC: A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1986;16:1195-1202.
12. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, and Zöller M: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993;177: 443-455.
13. Sy BMS, Guo YJ, and Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 1991;174:859-866.
14. Aruffo A, Stamenkovic I, Melnick M, Underbill CB, and Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
15. Culty M, Ngyen HA, and Underbill CB: The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992;116:1055-1062.
16. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, and Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
17. Miyake K, Underbill CB, Lesley J, and Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75.
18. Underbill CB, Thum AL, and Lacy BE: Characterisation and identification of the hyaluronate binding site from membranes of SV-3T3 cells. J Biol Chem 1985;260:8128-8133.
19. Underbill CB, Green SJ, Comoglio PM, and Tarone G: The hyaluronate receptor is identical to a glycoprotein of 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. J Biol Chem 1987;262:13142-13146.
20. Alvarez OA, Carmichael DF, and De Clerck YA: Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990;82:589-595.
21. Davies B, Brown PD, Crimmen M, East N, and Balkwill FR: A synthetic metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice with ovarian carcinoma xenografts. Cancer Res 1993;53:2087-2091.